The expression and clinical significance of serum exosomal-long non-coding RNA DLEU1 in patients with cervical cancer
2024

Serum Exosomal DLEU1 in Cervical Cancer

Sample size: 134 publication 10 minutes Evidence: moderate

Author Information

Author(s): Y. Chen, Cui Facai, Wu Xiaoyu, Zhao Weifeng, Xia Qingxin

Primary Institution: The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital

Hypothesis

The clinical significance of serum exosomal DLEU1 in patients with cervical cancer remains unclear.

Conclusion

Serum exosome DLEU1 has clinical value for diagnosing, monitoring recurrence and metastasis, and evaluating cervical cancer prognosis.

Supporting Evidence

  • DLEU1 expression in serum exosomes was significantly upregulated in patients with cervical cancer compared to healthy controls.
  • DLEU1 was correlated with tumor size, invasion depth, and lymph node metastasis.
  • The combined detection of DLEU1, CA-125, and SCC showed higher diagnostic efficiency.

Takeaway

This study found that a specific molecule in the blood, called DLEU1, can help doctors tell if someone has cervical cancer and how serious it is.

Methodology

The expression of serum exosomal DLEU1 was detected by quantitative real-time polymerase chain reaction (qRT-PCR), and its clinical diagnostic efficacy was evaluated using ROC curve analysis.

Limitations

The sample size was small, and all patients were from the same hospital, which may affect the generalizability of the results.

Participant Demographics

The age of the 134 patients with cervical cancer ranged from 27 to 71 years, with an average age of 43.7 years.

Statistical Information

P-Value

p<0.001

Confidence Interval

95% CI: 0.755–0.862

Statistical Significance

p<0.001

Digital Object Identifier (DOI)

10.1080/07853890.2024.2442537

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication